Basic Information
Amathus Therapeutics is a biopharmaceutical company and a leader in the field of organelle-specific chaperone small molecule modulators, which are involved in a variety of genetically defined diseases, including Parkinson's disease (PINK1) and polycystic kidney disease (ADPKD).
Amathus Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2016
contact@amathustx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios